Healthcare provider profile · identity verified

Robert Burl Rook, MD

Family Practice · CONWAY, AR · NPI 1467487751

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	352	57
Levothyroxine Sodium	Levothyroxine Sodium	309	54
Pantoprazole Sodium	Pantoprazole Sodium	306	60
Gabapentin	Gabapentin	239	44
Zolpidem Tartrate	Zolpidem Tartrate	209	31
Alprazolam	Alprazolam	182	31
Omeprazole	Omeprazole	182	32
Losartan Potassium	Losartan Potassium	177	40
Amlodipine Besylate	Amlodipine Besylate	153	38
Tamsulosin Hcl	Tamsulosin Hcl	150	29
Lisinopril	Lisinopril	141	30
Metoprolol Tartrate	Metoprolol Tartrate	140	28
Rosuvastatin Calcium	Rosuvastatin Calcium	125	24
Furosemide	Furosemide	116	28
Sertraline Hcl	Sertraline Hcl	105	15
Cephalexin	Cephalexin	103	50
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	102	22
Diclofenac Sodium	Diclofenac Sodium	101	22
Albuterol Sulfate Hfa	Albuterol Sulfate	100	50
Allopurinol	Allopurinol	100	22
Potassium Chloride	Potassium Chloride	99	25
Amitriptyline Hcl	Amitriptyline Hcl	97	11
Meloxicam	Meloxicam	97	28
Celecoxib	Celecoxib	93	13
Lorazepam	Lorazepam	90	12
Carvedilol	Carvedilol	88	14
Clonazepam	Clonazepam	88	17
Duloxetine Hcl	Duloxetine Hcl	87	17
Trazodone Hcl	Trazodone Hcl	86	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	85	53
Metformin Hcl	Metformin Hcl	85	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	77	33
Glipizide Er	Glipizide	77	17
Oxybutynin Chloride Er	Oxybutynin Chloride	77	13
Pioglitazone Hcl	Pioglitazone Hcl	77	11
Citalopram Hbr	Citalopram Hydrobromide	76	16
Fluoxetine Hcl	Fluoxetine Hcl	75	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	74	suppressed
Glipizide	Glipizide	73	12
Atorvastatin Calcium	Atorvastatin Calcium	71	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	suppressed
Azithromycin	Azithromycin	67	51
Diazepam	Diazepam	64	suppressed
Prednisone	Prednisone	64	23
Pravastatin Sodium	Pravastatin Sodium	59	15
Clopidogrel	Clopidogrel Bisulfate	56	13
Metoprolol Succinate	Metoprolol Succinate	55	13
Tizanidine Hcl	Tizanidine Hcl	53	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	34
Escitalopram Oxalate	Escitalopram Oxalate	47	suppressed
Simvastatin	Simvastatin	47	suppressed
Tramadol Hcl	Tramadol Hcl	47	13
Atenolol	Atenolol	46	suppressed
Mirtazapine	Mirtazapine	45	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	12
Pregabalin	Pregabalin	45	suppressed
Cefdinir	Cefdinir	44	27
Fluconazole	Fluconazole	44	22
Nifedipine Er	Nifedipine	44	suppressed
Mounjaro	Tirzepatide	43	suppressed
Estradiol	Estradiol	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Finasteride	Finasteride	41	suppressed
Ondansetron Hcl	Ondansetron Hcl	41	16
Fluticasone Propionate	Fluticasone Propionate	40	15
Hydrochlorothiazide	Hydrochlorothiazide	38	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Valacyclovir	Valacyclovir Hcl	37	14
Aripiprazole	Aripiprazole	35	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Jardiance	Empagliflozin	35	suppressed
Amoxicillin	Amoxicillin	34	24
Clonidine Hcl	Clonidine Hcl	34	suppressed
Promethazine Hcl	Promethazine Hcl	33	suppressed
Etodolac	Etodolac	32	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Methylprednisolone	Methylprednisolone	30	25
Buspirone Hcl	Buspirone Hcl	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Levofloxacin	Levofloxacin	28	19
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	27	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	26	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Temazepam	Temazepam	24	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Eliquis	Apixaban	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	20	suppressed
Metronidazole	Metronidazole	19	15
Folic Acid	Folic Acid	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Silodosin	Silodosin	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Baclofen	Baclofen	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Famotidine	Famotidine	14	suppressed
Ivermectin	Ivermectin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Haloperidol	Haloperidol	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sucralfate	Sucralfate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error